Tag: venture capital

June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: Caladrius Soars 77 Percent

Caladrius Biosciences, Bellerophon Therapeutics, Celsion, Albireo Pharma and Trillium Therapeutics were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 31, 2018

8 Anti-Aging Company Stocks

Here is a look at four stocks and a big ETF searching for novel therapies in the quest for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018

Village Capital Plugs Electric Vehicles in New Report

The firm highlights that the EV charging technology–which is currently at $2.1 billion–is projected to reach $8 billion by 2022.
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018

Funding for Canadian Fintech Companies Declines 60 Percent in Q1

Although investment in Canadian fintech companies fell in Q1, overall venture capital investment set a new record of $1 billion...
April 24, 2018

VIDEO — International Battery Metals: We’ve Got a Perfect Storm in Lithium

Dr. John Burba of International Battery Metals discusses the lithium market and his company's lithium extraction technology.
April 17, 2018

Victory Square Enters Into Definitive Agreement to Acquire 9.09% of LocoNoco

Victory Square Technologies (CSE:VST) has announced that it will acquire 9.09 percent of the issued and outstanding shares of LocoNoco...
April 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Novelion on Top

Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week's top gainers.